propranolol has been researched along with rolipram in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Alen, J; Boland, S; Boumans, N; Bourin, A; Castermans, K; Defert, O; Leysen, D; Panitti, L; Vanormelingen, J | 1 |
| Bucki, A; Chrzanowska, A; Czopek, A; Drop, M; Głuch-Lutwin, M; Kołaczkowski, M; Partyka, A; Pawłowski, M; Pękala, E; Siwek, A; Struga, M; Wesołowska, A; Zagórska, A | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Conanan, ND; Ellis, JL | 1 |
| Ellis, JL; Fernandes, LB; Undem, BJ | 1 |
| Cheng, JB; Griffiths, RJ; Labasi, JM; Pettipher, ER; Salter, ED; Stam, EJ | 1 |
| O'Donnell, JM; Ye, Y | 1 |
| Bochnowicz, S; Matthews, JK; Osborn, RR; Torphy, TJ; Underwood, DC | 1 |
| Eskra, JD; Labasi, JM; Pettipher, ER | 1 |
| Cheng, JB; Cohen, VL; Jayasinghe-Beck, R; Turner, CR; Watson, JW; Wright, KF | 1 |
| Chen, M; Conti, M; Farooqui, SM; Houslay, MD; O'Donnell, JM; Ye, Y | 1 |
| Chapman, RW; Crawley, Y; Kreutner, W; Kung, TT; Luo, B; Young, S | 1 |
| Cueff, A; Lacoste, A; Malham, SK; Poulet, SA | 1 |
| Abel, D; Danuser, H; Mettler, D; Scholtysik, G; Studer, UE; Walter, B; Weiss, R | 1 |
| Bobalova, J; Mutafova-Yambolieva, VN; Smyth, L | 1 |
| Cancino, J; González, A; Jung, JE; Metz, C; Norambuena, A; Otero, C; Retamal, C; Silva, A; Soza, A; Valenzuela, JC | 1 |
| Spindler, V; Waschke, J | 1 |
| Abella, LMR; Gergs, U; Hoffmann, R; Hofmann, B; Neumann, J | 1 |
19 other study(ies) available for propranolol and rolipram
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Novel Roflumilast analogs as soft PDE4 inhibitors.
Topics: Aminopyridines; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dose-Response Relationship, Drug; Humans; Hydrolysis; Molecular Structure; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship | 2014 |
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Humans; Receptors, Serotonin; Structure-Activity Relationship | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Atropine; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Electric Stimulation; Guanidines; Guinea Pigs; Indomethacin; Isoenzymes; Muscle Relaxation; Nitric Oxide; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Propranolol; Purinones; Pyridazines; Pyrrolidinones; Receptors, Adrenergic; Receptors, Cholinergic; Rolipram; Trachea; Vasoactive Intestinal Peptide; Xanthines | 1995 |
Potentiation of nonadrenergic noncholinergic relaxation of human isolated bronchus by selective inhibitors of phosphodiesterase isozymes.
Topics: Atropine; Bronchi; Colforsin; Electric Stimulation; Histamine; Humans; In Vitro Techniques; Indomethacin; Isoenzymes; Molsidomine; Muscle Relaxation; Nitroprusside; Phosphodiesterase Inhibitors; Propranolol; Purinones; Pyrrolidinones; Rolipram | 1994 |
Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.
Topics: Adrenalectomy; Animals; Anti-Inflammatory Agents, Non-Steroidal; Corticosterone; Escherichia coli; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mifepristone; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rolipram; Tumor Necrosis Factor-alpha | 1996 |
Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Binding, Competitive; Cerebral Cortex; Cyclic AMP; Dose-Response Relationship, Drug; Hydrolysis; Injections, Intraventricular; Isoproterenol; Male; Norepinephrine; Oxidopamine; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram | 1996 |
The influence of endogenous catecholamines on the inhibitory effects of rolipram against early- and late-phase response to antigen in the guinea pig.
Topics: Adrenalectomy; Animals; Antigens; Catecholamines; Cimetidine; Guinea Pigs; Indomethacin; Male; Nadolol; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rolipram | 1997 |
The inhibitory effect of rolipram on TNF-alpha production in mouse blood ex vivo is dependent upon the release of corticosterone and adrenaline.
Topics: Adrenalectomy; Adrenergic beta-Antagonists; Animals; Corticosterone; Epinephrine; Hormone Antagonists; Male; Mice; Mice, Inbred BALB C; Mifepristone; Monocytes; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rolipram; Tumor Necrosis Factor-alpha | 1997 |
Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Animals; Bronchodilator Agents; Catecholamines; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Guinea Pigs; Male; Muscle Relaxation; Muscle, Smooth; Phosphodiesterase Inhibitors; Propranolol; Pyridazines; Pyrimidinones; Pyrrolidinones; Rolipram; Trachea | 1997 |
Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Binding, Competitive; Brain; Desipramine; Immunoblotting; Male; Norepinephrine; Oxidopamine; Phosphodiesterase Inhibitors; Propranolol; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Time Factors | 1997 |
Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines.
Topics: Animals; Antihypertensive Agents; Bronchial Hyperreactivity; Bronchoalveolar Lavage; Catecholamines; Corticosterone; Drug Interactions; Hypersensitivity; Male; Metyrapone; Mice; Phosphodiesterase Inhibitors; Propranolol; Pulmonary Eosinophilia; Rolipram | 2000 |
Noradrenaline modulates oyster hemocyte phagocytosis via a beta-adrenergic receptor-cAMP signaling pathway.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Flow Cytometry; Hemocytes; Isoproterenol; Isoquinolines; Microscopy, Confocal; Naphthalenes; Norepinephrine; Ostreidae; Phagocytosis; Phenylephrine; Phosphodiesterase Inhibitors; Prazosin; Propranolol; Protein Kinase C; Receptors, Adrenergic, beta; Rolipram; Signal Transduction; Sulfonamides | 2001 |
Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Female; Fenoterol; Injections, Intravenous; Isoproterenol; Male; Muscle Contraction; Papaverine; Phenylephrine; Phosphodiesterase Inhibitors; Prazosin; Propranolol; Rolipram; Swine; Ureter | 2001 |
Involvement of cyclic AMP-mediated pathway in neural release of noradrenaline in canine isolated mesenteric artery and vein.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Animals; Autonomic Nervous System; Bucladesine; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dogs; Edetic Acid; Electric Stimulation; Isoproterenol; Mesenteric Arteries; Mesenteric Veins; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Propranolol; Rolipram; Second Messenger Systems | 2003 |
Phosphatidic acid induces ligand-independent epidermal growth factor receptor endocytic traffic through PDE4 activation.
Topics: Adrenergic beta-Antagonists; Animals; Clathrin; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 4; Endocytosis; Endosomes; Enzyme Activation; ErbB Receptors; Flow Cytometry; HeLa Cells; Humans; Hydrolysis; Immunoblotting; Mice; NIH 3T3 Cells; Phosphatidic Acids; Phospholipase D; Propranolol; RNA Interference; Rolipram; Signal Transduction | 2010 |
Beta-adrenergic stimulation contributes to maintenance of endothelial barrier functions under baseline conditions.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antigens, CD; Cadherins; Capillary Permeability; Cells, Cultured; Cyclic AMP; Electric Impedance; Endothelium, Vascular; Enzyme Activation; Epinephrine; Female; Gap Junctions; Humans; Male; Phosphodiesterase 4 Inhibitors; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Rolipram; Signal Transduction; Venules | 2011 |
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.
Topics: Animals; Atrial Fibrillation; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; Mice; Myocardial Contraction; Phosphorylation; Propranolol; Rolipram; Simendan | 2023 |